Clinical Trials Directory

Trials / Completed

CompletedNCT06127394

Efficacy of Sacral Erector Spinae Plane Block (SESPB) on Postoperative Pain and Catheter-related Bladder Discomfort

Comparison of the Efficacy of Sacral Erector Spinae Plane Block (SESPB) and Pudendal Block on Postoperative Pain and Catheter-related Bladder Discomfort (CRBD) in Patients Undergoing Trans-urethral Resection of the Prostate (TUR-P).

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Giresun University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the catheter related bladder discomfort in patients who will undergoing TUR-P operation. The main questions it aims to answer are: * Is sacral ESPB effective on the pudendal nerve dermatome? * Is sacral ESPB as useful as pudendal block on CRBD? Participants will be divided into two groups and the first group will receive sacral espb after TUR-p operation and the second group will receive pudendal block. Investigators will be present for 24 hours * catheter related bladder discomfort * post-operative pain, * additional analgesic needs will be questioned and the difference between the two groups will be evaluated.

Detailed description

This is a prospective,randomised,double-blind, single-centre,study aiming to compare the effectiveness of US guided bilateral sacral ESPB and US guided bilateral pudendal block on CRBD and pain after TUR-P. 54 patients will be included in the study and divided into two groups. All patients will be standardly monitored and will receive general anaesthesia. At the end of the cases, sacral ESPB will be applied to the first group and pudendal block to the second group, and the patients and the data questioner physician will be blinded to the study. Primary and secondary outcomes will be questioned for 24 hours and statistics will be made according to the result.

Conditions

Interventions

TypeNameDescription
PROCEDURESacral ESP BlockSacral ESPB median approach, 40 ml %0,25 Bupivacaine
PROCEDUREPudendal BlockBilateral pudendal block, 10 ml %0,25 bupivacaine

Timeline

Start date
2023-11-12
Primary completion
2023-12-15
Completion
2023-12-15
First posted
2023-11-13
Last updated
2024-05-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06127394. Inclusion in this directory is not an endorsement.